Analysis of Teva Pharmaceutical Industries
Teva Pharmaceutical Industries is a leading generic drugs manufacturer in the world. Apart from the manufacturing of generic drugs, the company also has interests in active pharmaceutical ingredients (APIs) and in proprietary pharmaceuticals. As of 2015, Teva was the largest generic drug manufacturer in the world and also comes in the 15 biggest pharmaceutical companies globally.
Aruvian Research presents Analysis of Teva Pharmaceutical Industries. A complete and comprehensive analysis of Teva Pharmaceutical Industries, includes an overview of the industry the company operates in, a PEST Framework Analysis of the industry, and then moves on to analyzing the company itself.
Company analysis from Aruvian includes a history of Teva Pharmaceutical Industries, a business segment analysis of the segments Teva Pharmaceutical Industries operates through, a look at the organization structure of the company, a geographical operating segments analysis, an analysis of the company’s major competitors.
A financial analysis of Teva Pharmaceutical Industries is presented in the report which includes a ratio analysis, basic profit and loss analysis, presentation of the company balance sheet, and much more.
A SWOT Framework Analysis of Teva Pharmaceutical Industries and seven of its competitors completes this in-depth company analysis.
Aruvian Research presents Analysis of Teva Pharmaceutical Industries. A complete and comprehensive analysis of Teva Pharmaceutical Industries, includes an overview of the industry the company operates in, a PEST Framework Analysis of the industry, and then moves on to analyzing the company itself.
Company analysis from Aruvian includes a history of Teva Pharmaceutical Industries, a business segment analysis of the segments Teva Pharmaceutical Industries operates through, a look at the organization structure of the company, a geographical operating segments analysis, an analysis of the company’s major competitors.
A financial analysis of Teva Pharmaceutical Industries is presented in the report which includes a ratio analysis, basic profit and loss analysis, presentation of the company balance sheet, and much more.
A SWOT Framework Analysis of Teva Pharmaceutical Industries and seven of its competitors completes this in-depth company analysis.
A. EXECUTIVE SUMMARY
B. LOOKING AT THE INDUSTRY
B.1 Industry Definition
B.2 Brief Profile of the Industry
B.3 Impacts on the Industry
B.4 Challenges Facing the Industry
B.5 Future Perspective
C. INDUSTRY PEST FRAMEWORK ANALYSIS
C.1 Political Aspects
C.2 Economic Aspects
C.3 Social Aspects
C.4 Technological Aspects
D. LOOKING AT THE COMPANY
D.1 Company Profile
D.2 History of the Company
D.3 Ownership Pattern in the Company
D.4 Organizational Divisions
D.5 Profiling the Key Executives
D.6 Products & Services
E. LOOKING AT BUSINESS
E.1 Business Segments
E.2 Geographical Segments
E.3 Company Subsidiaries
F. SWOT FRAMEWORK ANALYSIS
F.1 Strengths to Build Upon
F.2 Weaknesses to Overcome
F.3 Opportunities to Exploit
F.4 Threats to Overcome
G. PROFILING THE COMPETITION (INCLUDES A CORPORATE PROFILE, BUSINESS SEGMENT ANALYSIS, FINANCIAL ANALYSIS AND A SWOT ANALYSIS OF COMPETITOR COMPANIES)
G.1 Abbott Laboratories
G.2 AstraZeneca Plc
G.3 Biogen Inc.
G.4 Bristol-Myers Squibb Co
G.5 Merck & Co. Inc.
G.6 Novartis AG
G.7 Sanofi SA
H. FINANCIAL ANALYSIS OF THE COMPANY
H.1 Current Financials
H.2 Balance Sheet
H.3 Profit & Loss Statement
H.4 Ratio Analysis
I. FUTURE PERSPECTIVE
B. LOOKING AT THE INDUSTRY
B.1 Industry Definition
B.2 Brief Profile of the Industry
B.3 Impacts on the Industry
B.4 Challenges Facing the Industry
B.5 Future Perspective
C. INDUSTRY PEST FRAMEWORK ANALYSIS
C.1 Political Aspects
C.2 Economic Aspects
C.3 Social Aspects
C.4 Technological Aspects
D. LOOKING AT THE COMPANY
D.1 Company Profile
D.2 History of the Company
D.3 Ownership Pattern in the Company
D.4 Organizational Divisions
D.5 Profiling the Key Executives
D.6 Products & Services
E. LOOKING AT BUSINESS
E.1 Business Segments
E.2 Geographical Segments
E.3 Company Subsidiaries
F. SWOT FRAMEWORK ANALYSIS
F.1 Strengths to Build Upon
F.2 Weaknesses to Overcome
F.3 Opportunities to Exploit
F.4 Threats to Overcome
G. PROFILING THE COMPETITION (INCLUDES A CORPORATE PROFILE, BUSINESS SEGMENT ANALYSIS, FINANCIAL ANALYSIS AND A SWOT ANALYSIS OF COMPETITOR COMPANIES)
G.1 Abbott Laboratories
G.2 AstraZeneca Plc
G.3 Biogen Inc.
G.4 Bristol-Myers Squibb Co
G.5 Merck & Co. Inc.
G.6 Novartis AG
G.7 Sanofi SA
H. FINANCIAL ANALYSIS OF THE COMPANY
H.1 Current Financials
H.2 Balance Sheet
H.3 Profit & Loss Statement
H.4 Ratio Analysis
I. FUTURE PERSPECTIVE
